Humanwell Healthcare
Humanwell Healthcare
Humanwell Healthcare insists on R&D as the guide
Humanwell Healthcare insists on R&D as the guide, and is at the forefront of R&D investment and new drug R&D progress among domestic pharmaceutical enterprises, and is committed to building a first-class platform for R&D and industrialization of new drugs in China.
- All
- News
- Analysis
- Research
Briefing Dec 04, 2021 09:35 AM
· Healthcare
Keytruda melanoma can adapt to a wider range of patients
Briefing Dec 04, 2021 09:31 AM
· Healthcare
Fuhong Hanlin bevacizumab approved in China
In depth
Healthcare
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
Briefing Dec 03, 2021 06:31 PM
· Healthcare
Beida pharmaceutical's second Hong Kong stock IPO
Apr 22, 2021 03:11 PM
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Research
Real Estate, Industrials, FinancialsTech for Global, Globalization Footprints of the Established and the New
May 29, 2020 08:30 PM
Briefing Dec 03, 2021 10:00 AM
· Healthcare
The world's leading intelligent hearing aid "Zhiyin" won tens of millions of yuan of pre-A investment, which was invested by Qingsong fund, Xiaomi war investment and Shunwei capital
Briefing Dec 02, 2021 09:54 AM
· Healthcare
Pfizer vaccine R & D director will switch to GlaxoSmithKline
Insight
Briefing Jul 07, 2021 03:24 PM
· Healthcare
The first bank of China fund to release its second Quarterly Report
See more
Related Companies
EqualOcean Analysis
- Genetron Health's Self-Developed Mutation Capsule Differentiates It from Others
- Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
- China Speed: Two COVID-19 Vaccines Recognized by WHO
- After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
- More Room for the Medical Device Market to Grow in China
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.